Literature DB >> 19344823

For which glaucoma suspects is it appropriate to initiate treatment?

.   

Abstract

OBJECTIVE: Because uncertainty exists about which glaucoma suspects should be treated, this study sought to identify the glaucoma suspects who an expert panel could agree would be appropriate or inappropriate to treat.
DESIGN: The RAND/UCLA appropriateness method, a well-established procedure to synthesize the scientific literature with expert opinion to resolve uncertainty on a health topic. PARTICIPANTS: Eleven-member panel composed of recognized international leaders in the field of glaucoma.
METHODS: Based on a systematic review of the literature on potentially important factors to consider when deciding to initiate treatment, more than 1000 scenarios of glaucoma suspects initially were created. The panel formally rated the appropriateness of initiating treatment for glaucoma suspects through a 2-round modified Delphi method, a technique that preserves the confidentiality of individual panelists'ratings but allows panelists to compare their own ratings with those of the entire panel. MAIN OUTCOME MEASURES: Final ratings for scenarios were categorized as appropriate, uncertain, or inappropriate to treat according to typical prespecified statistical criteria previously used in projects using the RAND/UCLA appropriateness method. Tools were developed to help clinicians to approximate the panel ratings of glaucoma suspects.
RESULTS: The panel chose age, life expectancy, intraocular pressure (IOP), central corneal thickness, cup-to-disc ratio, disc size, and family history as the variables to consider when deciding whether to treat glaucoma suspects. Permutations of these variables created 1800 unique scenarios. The panel rated 587 (33%) scenarios as appropriate, 585 (33%) as uncertain, and 628 (35%) as inappropriate for treatment initiation. Analysis of variance determined that IOP had greater impact than any other variable on panel ratings. A point system was created with 96% sensitivity and 93% specificity for predicting panel ratings of appropriateness for a glaucoma suspect.
CONCLUSIONS: An expert panel can reach agreement on the appropriateness and inappropriateness of treatment for glaucoma suspects.

Entities:  

Mesh:

Year:  2009        PMID: 19344823      PMCID: PMC2722433          DOI: 10.1016/j.ophtha.2008.12.065

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Effect of specialty and nationality on panel judgments of the appropriateness of coronary revascularization: a pilot study.

Authors:  S J Bernstein; P Lázaro; K Fitch; M D Aguilar; J P Kahan
Journal:  Med Care       Date:  2001-05       Impact factor: 2.983

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

3.  Visual acuity following cataract surgeries in relation to preoperative appropriateness ratings.

Authors:  Joanne K Tobacman; Bridget Zimmerman; Paul Lee; Lee Hilborne; Hansjoerg Kolder; Robert H Brook
Journal:  Med Decis Making       Date:  2003 Mar-Apr       Impact factor: 2.583

4.  The appropriateness method.

Authors:  Paul Shekelle
Journal:  Med Decis Making       Date:  2004 Mar-Apr       Impact factor: 2.583

Review 5.  Consensus methods for medical and health services research.

Authors:  J Jones; D Hunter
Journal:  BMJ       Date:  1995-08-05

6.  Derivation of clinical indications for carotid endarterectomy by an expert panel.

Authors:  N J Merrick; A Fink; R E Park; R H Brook; J Kosecoff; M R Chassin; D H Solomon
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

7.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

8.  Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer.

Authors:  R P Gale; R E Park; R Dubois; J D Bitran; A Buzdar; G Hortobagyi; S E Jones; G S Lazar; G Spitzer; S M Swain; C B Vaughn; C E Vogel; S Martino
Journal:  Clin Transplant       Date:  2000-02       Impact factor: 2.863

9.  Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.

Authors:  Mae O Gordon; Valter Torri; Stefano Miglior; Julia A Beiser; Irene Floriani; J Philip Miller; Feng Gao; Ingrid Adamsons; Davide Poli; Ralph B D'Agostino; Michael A Kass
Journal:  Ophthalmology       Date:  2006-11-07       Impact factor: 12.079

10.  The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Authors:  Murray D Krahn; Karen E Bremner; Jamil Asaria; Shabbir M H Alibhai; Robert Nam; George Tomlinson; Michael A S Jewett; Padraig Warde; Gary Naglie
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

View more
  4 in total

1.  [Arguments for prophylactic therapy of ocular hypertension].

Authors:  J Wahl
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

2.  Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians.

Authors:  Eliza B Geer; Alejandro Ayala; Vivien Bonert; John D Carmichael; Murray B Gordon; Laurence Katznelson; Ekaterina Manuylova; Ismat Shafiq; Vijaya Surampudi; Ronald S Swerdloff; Michael S Broder; Dasha Cherepanov; Marianne Eagan; Jackie Lee; Qayyim Said; Maureen P Neary; Beverly M K Biller
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

Review 3.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Glaucoma public service announcements: factors associated with follow-up of participants with risk factors for glaucoma.

Authors:  Zakary Hoffelt; Shawn Fallon; Brad A Wong; Betty Lucas; Anne L Coleman; Richard P Mills; Richard Wilson; Steven L Mansberger
Journal:  Ophthalmology       Date:  2011-03-24       Impact factor: 12.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.